stockcue

BTAI (BioXcel Therapeutics, Inc.): Stockcue Score 40/100 — Weak profile · Valuation 30/100 · Financial health 14/100 · Growth 82/100 · price $0.07. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s